TABLE 2.

Concentration of PUFAs (ng/mL) in the synovial fluid of the control, model, SH, and MSC groups.

Name	Control group		Model group		SH group		MSC group
	Concentration	RSD (%)	Concentration	RSD (%)	Concentration	RSD (%)	Concentration	RSD (%)
15(S)-HETE	-	-	1.52	17.82	0.76	31.66	-	-
11(S)-HETE	0.44	24.96	3.84	16.53	1.42	21.38	-	-
12(S)-HETE	5,572.46	7.03	8,897.64	16.23	3,773.31	12.66	4,803.63	17.72
5(S)-HETE	44.19	18.52	219.65	26.69	56.84	6.99	35.19	26.16
PGA2	0.10	20.13	0.53	15.72	0.14	25.99	0.050	25.57
PGB2	0.14	23.63	0.21	18.93	0.062	24.64	0.042	29.23
PGJ2	0.12	10.47	0.38	14.70	0.22	27.59	0.15	24.62
PGD2	0.084	6.06	0.11	18.32	0.039	9.85	0.060	22.10
PGE2	0.12	13.46	0.14	14.27	0.047	7.42	0.046	15.29
PGE1	0.58	13.14	1.02	14.08	0.33	16.88	0.32	19.46
PGF2α	2.85	10.71	4.43	18.99	1.61	18.36	1.85	17.56
PGF2β	0.17	11.90	0.19	20.39	0.050	10.46	0.034	27.09
6-keto-PGF1α	0.23	15.31	0.65	29.62	0.29	23.37	0.61	23.79
11β-PGF2α	0.17	9.60	0.22	16.19	0.089	9.79	0.093	24.62
DK-PGE2	0.33	15.58	0.44	16.72	0.12	26.92	0.21	20.34
15(S)-HETrE	6.87	8.16	7.68	16.67	4.97	21.41	7.02	14.91
12(S)-HHTrE	1,251.48	9.07	1,484.54	19.27	891.53	23.48	1,264.95	16.11
TXB2	19.65	11.57	24.49	21.67	16.53	21.08	15.41	24.01
5(S)-HEPE	0.46	8.28	0.41	8.81	0.70	27.97	1.04	23.57
12(S)-HEPE	9.47	24.07	7.51	13.98	7.66	23.59	11.09	12.25
15(S)-HEPE	0.21	21.26	0.19	15.90	0.27	22.63	0.26	10.82
13(S)-HOTrE	6.17	14.03	5.54	19.47	11.56	22.39	6.96	11.76